Filing Flows › Exagen (XGN) › Q1 2026 › vs Q4 2025
Exagen (XGN) Q1 2026 vs Q4 2025 (quarter over quarter)
Exagen's revenue rose $675K (+4%) from $16.6M in Q4 2025 to $17.3M in Q1 2026.
Exagen, Q1 2026: revenue $17.3M (+12% year over year), operating margin -19.7%, net loss $4.0M, operating cash flow −$10.4M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $17.3M | $16.6M | $675K | +4% |
| Net loss | $4.0M | $4.7M | −$706K | -15% |
| Costs & expenses | $21.3M | $21.6M | −$346K | -2% |
| Operating costs | $20.7M | $21.6M | −$886K | -4% |
| Interest & other, net | $517K | −$315K | $832K | — |
| Income tax | $36K | $13K | $23K | +177% |
| Cost of revenue | $7.1M | $7.4M | −$324K | -4% |
| Research & development | $1.6M | $1.8M | −$204K | -12% |
| SG&A | $12.1M | $12.4M | −$358K | -3% |
| Operating cash sources | $11.7M | $4.3M | $7.4M | +170% |
| Depreciation & amortization | $600K | $600K | $0 | 0% |
| Share-based compensation | $655K | $705K | −$50K | -7% |
| Cash used in operations | $10.4M | $3.0M | $7.4M | +246% |
| Net loss absorbed | $4.0M | $4.7M | −$706K | -15% |
| Working capital & other | $7.7M | −$355K | $8.1M | — |
Questions
How much did Exagen's revenue grow quarter over quarter in Q1 2026?
Exagen's revenue rose $675K (+4%) from $16.6M in Q4 2025 to $17.3M in Q1 2026.